Department of Clinical and Experimental Medicine/Clinical Chemistry, Linkoping University, Linkoping SE-581 85, Sweden.
Gen Comp Endocrinol. 2012 Jan 1;175(1):188-93. doi: 10.1016/j.ygcen.2011.11.014. Epub 2011 Nov 23.
Rodent models constitute a cornerstone in the elucidation of the effects and biological mechanisms of 17β-estradiol. However, a thorough assessment of the methods for long-term administration of 17β-estradiol to mice is lacking. The fact that 17β-estradiol has been demonstrated to exert different effects depending on dose emphasizes the need for validated administration regimens. Therefore, 169 female C57BL/6 mice were ovariectomized and administered 17β-estradiol using one of the two commonly used subcutaneous methods; slow-release pellets (0.18 mg, 60-day release pellets; 0.72 mg, 90-day release pellets) and silastic capsules (with/without convalescence period, silastic laboratory tubing, inner/outer diameter: 1.575/3.175 mm, filled with a 14 mm column of 36 μg 17β-estradiol/mL sesame oil), or a novel peroral method (56 μg 17β-estradiol/day/kg body weight in the hazelnut cream Nutella). Forty animals were used as ovariectomized and intact controls. Serum samples were obtained weekly for five weeks and 17β-estradiol concentrations were measured using radioimmunoassay. The peroral method resulted in steady concentrations within--except on one occasion--the physiological range and the silastic capsules produced predominantly physiological concentrations, although exceeding the range by maximum a factor three during the first three weeks. The 0.18 mg pellet yielded initial concentrations an order of magnitude higher than the physiological range, which then decreased drastically, and the 0.72 mg pellet produced between 18 and 40 times higher concentrations than the physiological range during the entire experiment. The peroral method and silastic capsules described in this article constitute reliable modes of administration of 17β-estradiol, superior to the widely used commercial pellets.
啮齿动物模型是阐明 17β-雌二醇作用和生物学机制的基石。然而,缺乏对长期给予小鼠 17β-雌二醇方法的全面评估。17β-雌二醇的作用因剂量而异这一事实强调了需要验证的给药方案。因此,将 169 只雌性 C57BL/6 小鼠去卵巢,并使用两种常用的皮下给药方法之一给予 17β-雌二醇; 缓释微球(0.18mg,60 天释放微球;0.72mg,90 天释放微球)和硅橡胶胶囊(有/无恢复期,硅橡胶实验室管,内/外径:1.575/3.175mm,填充 14mm 长 36μg/ml 17β-雌二醇/芝麻油),或一种新的口服方法(56μg 17β-雌二醇/天/kg 体重榛子奶油 Nutella)。40 只动物作为去卵巢和完整对照。每周采集血清样本 5 周,用放射免疫法测量 17β-雌二醇浓度。口服法除一次外,其余时间均能保持在生理范围内的稳定浓度,硅橡胶胶囊主要产生生理浓度,尽管在前 3 周内最高浓度可超过生理范围的 3 倍。0.18mg 微球的初始浓度比生理范围高一个数量级,然后急剧下降,0.72mg 微球在整个实验期间产生的浓度比生理范围高 18 至 40 倍。本文描述的口服法和硅橡胶胶囊是给予 17β-雌二醇的可靠方法,优于广泛使用的商业微球。